ORTEXORTEX News
Tracking JLL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
JL
Earnings PreviewJLL

JLL Short Interest Hits Year-High With Peers Outperforming

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 24 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short interest in JLL has climbed to its highest level in at least a year, with shares borrowed against the free float rising 63% over the past month to 2.6%, even as the borrow market itself remains wide open.

The positioning shift is the clearest signal ahead of Tuesday's Q3 print. Short interest has added 7.7% in the past week alone, reaching 1.21 million shares. That monthly build is striking relative to where JLL was trading in September, when short positions were closer to 740,000 shares. Despite the surge in shares borrowed, the lending market shows no sign of stress: availability is running at 3,884% of short interest, meaning roughly 44.9 million shares remain available to lend against the 1.2 million currently borrowed. Cost to borrow is 0.38%, down sharply from 0.66% two weeks ago. Shorts are building positions against a backdrop where entry is cheap and easy.

The price tells a related story. JLL has fallen 10.5% over the past month to $300.30, dropping another 3.9% on Thursday alone. That compares poorly with the week's peer moves: CWK rose 4.7% on the week, ZG gained 6.8%, and COMP added 6.8%. Even CBRE, which fell 7.3% on the week and 6% on Friday alone, has outperformed JLL on a monthly basis. The median weekly move across JLL's closest peers is roughly +3.2%; JLL delivered negative 1.7%. Options positioning reinforces the defensive lean: the put/call ratio is at 1.58, about 1.4 standard deviations above its 20-day average of 1.45. That is not an extreme reading, but it is running persistently above average and has held in that range all week.

The analyst community is less alarmed than the price implies. The consensus mean target is $406.80 against a current price of $300.30, implying roughly 35% upside from here. Keefe, Bruyette & Woods trimmed its target to $385 from $415 on October 9, maintaining its Outperform rating. Barclays raised its target to $401 in August, though its Equal-Weight stance signals it sees valuation as fair rather than cheap. UBS holds a Buy with a $445 target. The broad direction among those who have updated recently is cautious optimism: targets coming in from post-July highs, but no one pulling their rating. JLL's EV/EBITDA is 8.8x and its trailing PE is 11.4x, both modest for a diversified commercial real estate services business. The EPS momentum factor rank is 84 over 90 days, suggesting estimate revisions have been moving in the right direction.

The prior two earnings prints are worth noting. JLL gained 4.4% on the day of its July results, then extended to nearly 7% over the following five days. The April print added 2.1% on the day and 10.4% over the following week. Both reactions were positive and both extended after the initial move. CEO Christian Ulbrich sold $3.05 million in shares through a pre-arranged 10b5-1 plan in August at prices between $375 and $387, well above current levels. Director grant activity in October at unspecified prices is compensation mechanics rather than a signal.

Tuesday's report will test whether the recent short-interest build reflects genuine concern about commercial real estate transaction volumes or simply a tactical hedge into a stock that has significantly underperformed its peer group this month.

Stocks in this article

See the live data behind this article on ORTEX.

Open JLL on ORTEX →

How this article was generated

Generated
24 Oct 2026, 04:08
Data as of
24 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.